NRIX

NRIX

USD

Nurix Therapeutics Inc. Common stock

$12.260-0.040 (-0.325%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$12.300

Kõrge

$12.530

Madal

$12.160

Maht

1.16M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.2B

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

1.24M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $8.18Praegune $12.260Kõrge $29.56

Seotud uudised

Analyst Upgrades

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Needham analyst Gil Blum reiterates Nurix Therapeutics with a Buy and maintains $26 price target.

Vaata rohkem
Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target

BTIG analyst Jeet Mukherjee reiterates Nurix Therapeutics with a Buy and maintains $27 price target.

Vaata rohkem
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target
GlobeNewswire

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Vaata rohkem
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Vaata rohkem
Nurix Therapeutics to Participate in Upcoming Investor Conferences

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.